We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
1. Introduction 1.1. New psychoactive substances (NPS) have presented a…
Rt. Hon. Priti Patel MP Home Secretary 2 Marsham Street London SW1P 4DF…
On 18 July 2022 the Advisory Council on the Misuse of Drugs (ACMD)…
Professor Owen Bowden-Jones, Chair, Advisory Council on the Misuse of…
06 October 2023 Addendum to ACMD’s report on the use and harms of 2-benzyl…
Rt Hon Chris Philp MP Minister of State for Crime, Policing and Fire | 2…
15 December 2023 Third addendum to ACMD report on the use and harms of…
Rt Hon Chris Philp MP Minister of State for Crime, Policing and Fire 2…
5 April 2024 On 12 December 2023, the ACMD published a third addendum to…
This report reviews drug use in ethnic minority groups and outlines recommendations for further data collection.
ACMD Chair: Professor David Wood ACMD Harm Reduction, Treatment and…
May 2026 1. Introduction 1.1 The Advisory Council on the Misuse of Drugs…
ACMD review into the use and harms of SSCs and THCA to identify compounds causing harm which are not captured by the current generic definition for cannabinoids.
ACMD Chair: Prof Owen Bowden-Jones NPS Committee Secretary: Yetunde…
Professor David Wood Chair, Advisory Council on the Misuse of Drugs (ACMD)…
An overview of work carried out by the Advisory Council on the Misuse of Drugs (ACMD) from January 2023 to December 2025.
The report reviews the evidence on the use and harms of the novel benzodiazepine ethylbromazolam and recommends control under the Misuse of Drugs Act 1971.
Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).
Letter to the the Minister for Policing and Crime from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2026.
This response agrees with recommendations from the Advisory Council on the Misuse of Drugs (ACMD) in 3 reports about the control and scheduling of 5 medicines.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).